- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lantus (insulin glargine)
Total 3234 results
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); SanofiWithdrawnHyperglycemia | LeukemiaUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Newcastle UniversitySanofi; Medtronic; Newcastle-upon-Tyne Hospitals NHS Trust; Newcastle Primary Care...Completed
-
SanofiCompleted
-
HaEmek Medical Center, IsraelCompletedDiabetes Mellitus Type 2
-
Baylor College of MedicineCompletedType 1 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico
-
University of PalermoCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Germany, Israel, Czechia, Spain, Russian Federation, Romania, Puerto Rico, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Italy, Canada, Germany, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Germany, United Kingdom, Austria, Belgium, France, Ireland
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
University of GiessenSanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
Shenzhen Second People's HospitalUnknown
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Mexico, Russian Federation, Netherlands, Belgium, Italy, India, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, France, United Kingdom, Russian Federation, Germany, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
-
Vancouver General HospitalTerminatedPost-Transplant Glucocorticoid Induced DiabetesCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
SanofiCompleted
-
Eli Lilly and CompanyCompleted
-
SanofiCompletedDiabetes Mellitus Type 2
-
SanofiCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedDiabetes Mellitus, Type 2Turkey
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompleted
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Diabetes Care CenterUnknownDiabetes Mellitus Type 1United States
-
Biologics & Biosimilars Collective Intelligence...Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim and other collaboratorsCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
Novo Nordisk A/SCompleted
-
Mannkind CorporationTerminatedDiabetes, Type 1United States, Brazil
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Chronic Kidney DiseaseMexico, United States, Hungary, Ukraine, Brazil, Spain, Romania, South Africa, Poland
-
SanofiCompletedDiabetes Mellitus, Type 1Belarus
-
SanofiCompletedInsulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinDiabetes Mellitus, Type 2United States
-
SanofiCompletedDiabetes Mellitus, Type 2Austria, United Arab Emirates, Spain, Romania, Colombia, Korea, Republic of, Brazil, Greece, Italy, China, Denmark, India, Kuwait, Mexico, Taiwan, Turkey
-
Universidad Nacional de AsunciónCompletedHyperglycemia | DiabetesParaguay